Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Australian firms advance in mining and biotech sectors, but Opthea faces solvency issues.
Australian companies are making moves in mining and biotech.
Resolution Minerals acquired projects rich in antimony, gold, and copper, while Terra Metals showed potential for high-grade mineral concentrates.
In biotech, Prescient Therapeutics appointed Dr. Marissa Lim as Chief Medical Officer, enhancing its cancer therapy efforts.
Meanwhile, Opthea Limited faces solvency concerns after a key trial failure.
The ASX 200 saw a 1.82% rise last week but is expected to decline in the coming session, influenced by interest rates and tariff developments.
12 Articles
Las empresas australianas avanzan en los sectores de la minería y la biotecnología, pero Opthea se enfrenta a problemas de solvencia.